Allergan Aesthetics, an AbbVie company, has announced that the U.S. Food and Drug Administration (FDA) has approved SKINVIVE by JUVÉDERM® for reducing horizontal neck lines and improving neck appearance in adults aged 21 years and older.
With this approval, SKINVIVE becomes the first and only hyaluronic acid (HA) injectable specifically approved for treating neck lines, including wrinkles commonly associated with “tech-neck.” The treatment is designed to improve skin quality by helping the skin retain moisture, softness, and smoothness.
This marks the second FDA-approved indication for SKINVIVE. The injectable was first approved in 2023 to improve cheek skin smoothness in adults.
Neck wrinkles can develop for several reasons. Natural aging, prolonged sun exposure, significant weight loss, and frequent downward head positioning while using smartphones, tablets, or reading materials can all contribute to visible horizontal neck lines.
The increasing prevalence of technology use has led to the rise of the term “tech-neck,” referring to wrinkles that form due to repeated bending of the neck while looking down at digital devices.
SKINVIVE by JUVÉDERM® is designed to address these concerns through a minimally invasive treatment that requires little to no downtime.
SKINVIVE uses hyaluronic acid, a naturally occurring substance in the body that helps maintain skin hydration.
The injectable treatment helps the skin retain its natural moisture, resulting in smoother and healthier-looking skin. It is administered using an ultrafine needle or cannula and contains a small amount of lidocaine to improve patient comfort during the procedure.
According to the company, results can last for up to six months when optimal treatment is achieved. Some patients may require an optional touch-up session approximately one month after the initial treatment.
Clinical Study Showed Significant Improvement in Neck Lines
The FDA approval was supported by results from a randomized, multicenter, evaluator-blinded, controlled clinical study.
Study findings showed that 74.8% of participants treated with SKINVIVE experienced at least a one-point improvement on the Allergan Transverse Neck Lines Scale after one month of treatment.
Researchers also reported that:
These findings suggest that the treatment can provide both visible and lasting improvements in neck appearance.
Company Highlights Importance of New Approval
Darin Messina, Senior Vice President of Aesthetics Research and Development at AbbVie, said the approval reflects the company’s commitment to developing science-based aesthetic treatments that address unmet patient needs.
According to Messina, the approval expands Allergan Aesthetics’ portfolio of lower-face and neck treatment options while giving patients and providers access to a first-of-its-kind injectable treatment specifically developed for neck wrinkles and skin quality improvement.
Safety Profile Observed During Clinical Trial
Participants in the clinical study reported several treatment-related side effects, most of which were mild and temporary.
The most commonly reported reactions included:
The company noted that these reactions generally resolved within two weeks and did not require additional treatment.
Severe adverse events were reported in fewer than 5% of participants who experienced side effects during the study.
Specialized Training Required for Providers
As part of the FDA approval process, Allergan Aesthetics will provide a dedicated training program for healthcare professionals interested in administering SKINVIVE for neck treatment.
Providers must successfully complete this training before purchasing or using the product for patients.
The company expects the newly approved neck indication for SKINVIVE by JUVÉDERM® to become broadly available across the United States later this year.
SKINVIVE Expands Its Position in Aesthetic Medicine
The latest approval adds another use to the growing JUVÉDERM® portfolio and introduces a new treatment option for adults seeking improvement in neck appearance without surgery.
By targeting horizontal neck wrinkles linked to aging and daily technology use, SKINVIVE offers aesthetic providers a new approach to treating an area that has traditionally had limited injectable treatment options.